SCHEMBL17356299

SCHEMBL17356299

CC(C)(C)S(=O)(=O)Oc1ccc(F)c(C(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 3/20 0.42
ALDH1A1 P00352 1/20 0.41
HTR2A P28223 1/20 0.40
SLC6A4 P31645 1/20 0.40
KCNH2 Q12809 1/20 0.40
KCNN4 O15554 1/20 0.38
AR P10275 4/20 0.38
PLA2G7 Q13093 1/20 0.36
KIF11 P52732 2/20 0.36
ERAP1 Q9NZ08 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
THRB P10828 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17356309 0.86 HTR1D (0.43) SLC22A12ALDH1A1HTR2ASLC6A4KCNH2
SCHEMBL17352133 0.85 ALDH1A1 (0.53) SLC22A12ALDH1A1HTR2ASLC6A4KCNH2
SCHEMBL17356302 0.83 SLC22A12 (0.41) SLC22A12ALDH1A1HTR2ASLC6A4KCNH2
SCHEMBL17356304 0.82 HTR2A (0.42) SLC22A12ALDH1A1HTR2ASLC6A4KCNH2
SCHEMBL17352171 0.81 HTR2A (0.39) SLC22A12ALDH1A1HTR2ASLC6A4KCNH2
SCHEMBL17355682 0.79 ALDH1A1 (0.39) SLC22A12ALDH1A1HTR2ASLC6A4KCNH2
SCHEMBL17356434 0.78 MEN1 (0.50) SLC22A12ALDH1A1HTR2ASLC6A4KCNH2
SCHEMBL17356307 0.78 CA12 (0.41) SLC22A12HTR2ASLC6A4KCNH2AR
SCHEMBL17356305 0.78 PLA2G7 (0.39) SLC22A12ALDH1A1HTR2ASLC6A4KCNH2
SCHEMBL17356306 0.78 HTR2A (0.37) SLC22A12ALDH1A1HTR2ASLC6A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE UBE INDUSTRIES, LTD. (JP) 2015-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE HCN2, SCO2, HCN1 SLC22A12 236/4885ALDH1A1 1059/4885HTR2A 4567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.